Evidence map›Paper›PMID 28182661›Full record

ArticlePLoS computational biology2017

Representing high throughput expression profiles via perturbation barcodes reveals compound targets.

Tracey M Filzen, Peter S Kutchukian, Jeffrey D Hermes, Jing Li, Matthew Tudor

Abstract read
In one paragraph

Article in PLoS computational biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Topological network measures for drug repositioning.Briefings in bioinformatics · 2021
    Article
  8. Article
  9. Review
  10. Cross-modal representation alignment of molecular structure and perturbation-induced transcriptional profiles.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Automating drug discovery.Nature reviews. Drug discovery · 2018
    Review
  15. Deep Learning Benchmarks on L1000 Gene Expression Data.IEEE/ACM transactions on computational biology and bioinformatics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tracey M FilzenMedical Writing, Merck Research Laboratories, Upper Gwynedd, Pennsylvania, United States of America.ORCID 0000-0001-9276-9279
Peter S KutchukianInformatics, Merck Research Laboratories, Boston, Massachusetts, United States of America.
Jeffrey D HermesScreening & Protein Sciences, Merck Research Laboratories, North Wales, Pennsylvania, United States of America.ORCID 0000-0001-7360-8322
Jing LiScreening and Compound Profiling, Merck Research Laboratories, Kenilworth, New Jersey, United States of America.
Matthew TudorInformatics, Merck Research Laboratories, West Point, Pennsylvania, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High throughput mRNA expression profiling can be used to characterize the response of cell culture models to perturbations such as pharmacologic modulators and genetic perturbations. As profiling campaigns expand in scope, it is important to homogenize, summarize, and analyze the resulting data in a manner that captures significant biological signals in spite of various noise sources such as batch effects and stochastic variation. We used the L1000 platform for large-scale profiling of 978 representative genes across thousands of compound treatments. Here, a method is described that uses deep learning techniques to convert the expression changes of the landmark genes into a perturbation barcode that reveals important features of the underlying data, performing better than the raw data in revealing important biological insights. The barcode captures compound structure and target information, and predicts a compound's high throughput screening promiscuity, to a higher degree than the original data measurements, indicating that the approach uncovers underlying factors of the expression data that are otherwise entangled or masked by noise. Furthermore, we demonstrate that visualizations derived from the perturbation barcode can be used to more sensitively assign functions to unknown compounds through a guilt-by-association approach, which we use to predict and experimentally validate the activity of compounds on the MAPK pathway. The demonstrated application of deep metric learning to large-scale chemical genetics projects highlights the utility of this and related approaches to the extraction of insights and testable hypotheses from big, sometimes noisy data.

Indexed as

AnimalsCell Physiological PhenomenaDrug Evaluation, PreclinicalGene ExpressionGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansMolecular Targeted TherapyPharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID28182661
PMCPMC5300121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.